Search Browse Earnings

Lifevantage Corp — SlamSEC

Lifevantage Corp

Nasdaq:LFVN

Pharmaceutical Preparations·LEHI, UT

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Fife Steven R

CFO

Aure Carl

Revenue

$200.2M

-6.2% YoY

FY 2025

Adj. EBITDA

$7.9M

4.0% margin

FY 2025

Net Income

$2.9M

1.5% margin

FY 2025

EPS (Diluted)

$0.23

FY 2025

Stock Price

$4.74

-8.7%

2026-03-17

52W Range

$3.90 – $17.64

P/E Ratio

20.6x

Market Cap

$60.6M

Cash

$16.9M

FY 2025

Total Debt

$3.4M

FY 2019

Net Cash

$13.5M

FY 2019

Enterprise Value

$47.2M

Debt / EBITDA

-1.7x

FY 2025

EV / EBITDA

6.0x

Employees

—